Kurashiki, Japan

Takashi Nishida

This inventor holds 44 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Kuraray Co., Ltd., Taisho Pharmaceutical Co., Ltd., Kyowa Gas Chemical Industry Company, Ltd.. Active years: 1976-1994.


% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 8

Forward Citations = 197(Granted Patents)


Location History:

  • Kurashiki, JA (1976 - 1977)
  • Okayama, JP (1990 - 1992)
  • Kurashiki, JP (1978 - 1994)

Company Filing History:


Years Active: 1976-1994

Loading Chart...
Areas of Expertise:
Pharmaceutical Compositions
Polyprenyl Compounds
Pesticidal Formulations
Chroman Compounds
Trimethylcyclohexenyl Compounds
Hydroquinone Derivatives
Unsaturated Ketones
Isomerization
Aromatic Compounds
Squalane Production
Analgesics
Antioxidants
44 patents (USPTO):Explore Patents

Title: Takashi Nishida: Pioneering Inventor from Kurashiki

Introduction: Takashi Nishida is a renowned inventor hailing from Kurashiki, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Takashi Nishida holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous dedication to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Nishida has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Takashi Nishida has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Takashi Nishida's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a visionary inventor in the global tech community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…